Global Angiostomy Cannula Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Cardiac Cannula, Vascular Cannula, Arthroscopy Cannula, Dermatology Cannula, Nasal Cannula, Floating Spinal Cannula, and Hysterosalpingography Cannula.By Application;
Cardiovascular Surgery, Oxygen Therapy, Diabetes Treatment, Neurology, General Surgery, and Cosmetic/Plastic Surgery.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Angiostomy Cannula Market (USD Million), 2021 - 2031
In the year 2023, the Global Angiostomy Cannula Market was valued at USD 1,834.92 million. The size of this market is expected to increase to USD 2,927.26 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.9%.
Angiostomy cannulas are instrumental in facilitating the delivery of fluids or medications directly into blood vessels or other bodily cavities, enabling precise and targeted interventions for patients requiring specialized medical care. These devices find widespread use in a myriad of medical procedures, including but not limited to vascular access, infusion therapy, and diagnostic imaging procedures.
The market for angiostomy cannulas is propelled by a multitude of factors, including the rising prevalence of chronic diseases necessitating long-term medical interventions, advancements in medical technology enhancing the efficacy and safety of cannula placement and usage, and the expanding geriatric population requiring increased medical attention and interventions. Additionally, the growing adoption of minimally invasive surgical techniques and the increasing demand for ambulatory care further contribute to the market's growth trajectory.
The global healthcare landscape's continual evolution, marked by increasing healthcare expenditure, infrastructure development, and healthcare accessibility initiatives, fosters an environment conducive to the proliferation of angiostomy cannulas. These devices serve as indispensable tools for medical professionals across various healthcare settings, including hospitals, ambulatory surgical centers, and specialty clinics, supporting a wide array of medical procedures and interventions aimed at improving patient outcomes and quality of life.
Global Angiostomy Cannula Market Recent Developments
-
In October 2022, the creators of the MIC-Cannula, designed for minimally invasive central aortic perfusion, were honored with the EACTS Techno-College Innovation Award 2022. This device facilitates antegrade perfusion in a minimally invasive environment.
-
In June 2022, Prollenium Medical Technologies, a Canadian firm dedicated to the research and manufacturing of dermal fillers, announced its acquisition of SofFil, a company specializing in the development of medical cannulas, to enhance its product offerings.
Segment Analysis
The Global Angiostomy Cannula Market is segmented by Type, Application, and Geography, type, which includes single-lumen cannulas, double-lumen cannulas, and multi-lumen cannulas. Single-lumen cannulas are primarily used for simple blood flow monitoring and dialysis, while double-lumen cannulas are commonly employed for procedures requiring more complex blood flow management, such as in cardiovascular surgeries. Multi-lumen cannulas are used in more advanced procedures where multiple functions, such as blood return and infusion, need to be carried out simultaneously. The increasing demand for complex surgeries and more advanced medical procedures is propelling the growth of the multi-lumen and double-lumen segments, offering more versatile solutions to healthcare providers.
In terms of application, angiostomy cannulas are mainly used in vascular access, dialysis, blood transfusions, and cardiovascular surgeries. Vascular access is one of the largest applications, with cannulas being used to facilitate easy and efficient blood access during a variety of medical procedures. Dialysis is another significant application, as patients with renal failure rely on angiostomy cannulas for the repeated access to blood vessels during dialysis treatments. Cardiovascular surgeries and blood transfusions also represent key segments, as cannulas are critical for safely managing blood flow and delivering treatments during surgeries or emergency interventions. The rising prevalence of chronic kidney diseases, cardiovascular conditions, and other vascular disorders is driving growth in these application areas.
Geographically, the Global Angiostomy Cannula Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a dominant share of the market due to the advanced healthcare infrastructure, high adoption of innovative medical devices, and the increasing incidence of chronic diseases, which require procedures involving angiostomy cannulas. Europe follows closely, driven by a robust healthcare system and the growing elderly population, which leads to a higher incidence of diseases requiring angiostomy interventions. Asia-Pacific is anticipated to witness the fastest growth in the coming years, driven by improving healthcare access, rising disposable incomes, and the growing prevalence of renal and cardiovascular diseases in the region. As a result, manufacturers are increasingly focusing on expanding their presence in these rapidly developing markets.
Global Angiostomy Cannula Segment Analysis
In this report, the Global Angiostomy Cannula Market has been segmented by Type, Application, and Geography.
Global Angiostomy Cannula Market, Segmentation by Type
The Global Angiostomy Cannula Market has been segmented by Type into Cardiac Cannula, Vascular Cannula, Arthroscopy Cannula, Dermatology Cannula, Nasal Cannula, Floating Spinal Cannula, and Hysterosalpingography Cannula.
Among the segmented types, Cardiac Cannulas stand out as vital tools utilized in cardiac surgery and interventional cardiology procedures. These cannulas facilitate cardiopulmonary bypass and enable the delivery of cardioplegia solution, ensuring myocardial protection during open-heart surgeries and interventions. Vascular Cannulas play a crucial role in vascular surgery and endovascular procedures, serving as conduits for blood flow diversion, perfusion, and access during vascular interventions such as angiography, angioplasty, stent placement, and thrombectomy.
Arthroscopy Cannulas are instrumental in minimally invasive orthopedic procedures, providing access to the joint space for diagnostic visualization, irrigation, and the introduction of surgical instruments during arthroscopic surgery. Dermatology Cannulas are utilized in dermatologic procedures such as liposuction, fat transfer, and filler injections, enabling precise delivery of medications and solutions into subcutaneous tissues with minimal trauma and scarring. Nasal Cannulas are essential devices in respiratory therapy, delivering supplemental oxygen to patients with respiratory insufficiency or chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA).
Floating Spinal Cannulas are specialized devices employed in spinal anesthesia and pain management procedures, facilitating the administration of local anesthetics and analgesics into the subarachnoid space for surgical anesthesia or postoperative pain relief. Lastly, Hysterosalpingography Cannulas are utilized in gynecological procedures for diagnostic imaging of the uterine cavity and fallopian tubes, enabling the injection of contrast media for hysterosalpingography examinations to assess tubal patency and uterine abnormalities.
Global Angiostomy Cannula Market, Segmentation by Application
The Global Angiostomy Cannula Market has been segmented by Application into Cardiovascular Surgery, Oxygen Therapy, Diabetes Treatment, Neurology, General Surgery, and Cosmetic/Plastic Surgery.
Cardiovascular Surgery stands as a primary application area for angiostomy cannulas, encompassing a wide spectrum of cardiac procedures ranging from coronary artery bypass grafting (CABG) to valve replacement surgeries. Angiostomy cannulas are essential tools in cardiopulmonary bypass circuits, facilitating extracorporeal circulation and maintaining myocardial perfusion during cardiac surgeries.
Oxygen Therapy represents another important application for angiostomy cannulas, particularly in the management of respiratory insufficiency and chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA). Nasal cannulas, a subtype of angiostomy cannulas, are commonly used to deliver supplemental oxygen to patients via the nasal passages, ensuring adequate oxygenation and respiratory support. Diabetes Treatment involves the use of angiostomy cannulas for insulin delivery in patients with diabetes mellitus who require continuous subcutaneous insulin infusion (CSII) therapy. These cannulas are employed in insulin pump systems to deliver insulin directly into the subcutaneous tissue, offering precise and controlled insulin administration to maintain blood glucose levels within target ranges.
Neurology encompasses a broad range of neurological procedures and interventions where angiostomy cannulas may be utilized, including cerebral angiography, embolization procedures for vascular malformations, and cerebrospinal fluid (CSF) drainage in conditions such as hydrocephalus. General Surgery involves the use of angiostomy cannulas in various surgical procedures, including laparoscopic and minimally invasive surgeries, where these devices facilitate access, visualization, and irrigation during surgical interventions. Cosmetic/Plastic Surgery represents an application area where angiostomy cannulas are utilized for fat grafting, liposuction, and dermal filler injections, enabling precise delivery of medications and solutions into subcutaneous tissues with minimal trauma and scarring.
Global Angiostomy Cannula Market, Segmentation by Geography
In this report, the Global Angiostomy Cannula Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Angiostomy Cannula Market Share (%), by Geographical Region, 2024
North America, comprising the United States and Canada, stands as a prominent market for angiostomy cannulas, driven by factors such as advanced healthcare infrastructure, high healthcare expenditure, and a significant prevalence of cardiovascular diseases and respiratory conditions. The region's robust regulatory environment and technological advancements contribute to the adoption of innovative angiostomy cannula products and procedures.
Europe, encompassing countries such as the United Kingdom, Germany, France, and Italy, represents another significant market for angiostomy cannulas, characterized by a well-established healthcare system, growing aging population, and increasing demand for minimally invasive surgical procedures. The region's emphasis on healthcare quality and patient safety fosters the adoption of advanced angiostomy cannula technologies and procedures.
The Asia Pacific region, including emerging economies such as China, India, and Japan, exhibits rapid market growth driven by factors such as increasing healthcare spending, expanding access to healthcare services, and rising prevalence of chronic diseases. The region's large patient population and growing demand for medical devices contribute to the adoption of angiostomy cannulas for various medical applications across different specialties.
The Middle East and Africa region presents opportunities for market expansion fueled by infrastructure development, urbanization, and rising healthcare investments. The region's growing burden of cardiovascular diseases, diabetes, and respiratory conditions drives the demand for angiostomy cannulas to support diagnostic and therapeutic interventions.
Latin America, comprising countries such as Brazil, Mexico, and Argentina, represents a burgeoning market for angiostomy cannulas, propelled by improving healthcare infrastructure, increasing healthcare expenditure, and a growing prevalence of chronic diseases. The region's evolving regulatory landscape and expanding access to medical technology contribute to market growth and adoption of angiostomy cannulas for diverse medical applications.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Angiostomy Cannula Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population
- Technological Advancements
-
Increasing Chronic Diseases - Chronic diseases, characterized by long-lasting and often persistent medical conditions, encompass a wide range of health ailments such as cardiovascular diseases, respiratory disorders, diabetes, neurodegenerative diseases, and certain types of cancers. As populations age and lifestyles become more sedentary, the incidence and prevalence of chronic diseases have been steadily rising, driving demand for medical interventions and treatments, including those involving angiostomy cannulas.
The aging population, coupled with changing lifestyle factors such as unhealthy diets, physical inactivity, and tobacco use, has contributed to the growing burden of chronic diseases globally. Chronic conditions often require long-term management and medical interventions to prevent complications, manage symptoms, and improve quality of life. Angiostomy cannulas play a crucial role in the management of many chronic diseases, facilitating diagnostic procedures, therapeutic interventions, and supportive care measures aimed at addressing underlying pathologies and improving patient outcomes.
In cardiovascular diseases, angiostomy cannulas are utilized in diagnostic procedures such as angiography to visualize blood vessels and identify blockages or abnormalities. They are also employed in interventional procedures such as angioplasty and stent placement to restore blood flow to the heart and peripheral arteries, thereby alleviating symptoms and reducing the risk of adverse cardiovascular events.
In respiratory disorders, angiostomy cannulas are used in oxygen therapy to deliver supplemental oxygen to patients with chronic respiratory insufficiency, such as chronic obstructive pulmonary disease (COPD) or cystic fibrosis. These cannulas enable patients to maintain adequate oxygenation levels, alleviate symptoms of breathlessness, and improve overall respiratory function, thereby enhancing quality of life and reducing the risk of respiratory complications.
Restraints
- Regulatory Compliance Burden
- Limited Reimbursement Policies
-
Potential Complications - One potential complication associated with angiostomy cannulas is the risk of infection. Insertion of a cannula into the body creates a pathway for microorganisms to enter the bloodstream, increasing the likelihood of catheter-related bloodstream infections (CRBSIs) and local site infections. These infections can lead to serious complications, including sepsis, tissue necrosis, and systemic inflammatory response syndrome (SIRS), necessitating prompt intervention and potentially prolonging hospital stays.
Mechanical complications such as catheter malpositioning, kinking, or migration can occur during cannula placement or subsequent use, compromising catheter function and efficacy. Malpositioned cannulas may fail to deliver medications or fluids as intended, leading to suboptimal treatment outcomes or necessitating additional interventions to correct placement.
Thrombosis and thromboembolism represent another significant concern associated with angiostomy cannulas, particularly in vascular access procedures. Thrombus formation within the cannula or at the insertion site can obstruct blood flow, impede catheter patency, and increase the risk of embolic events, including pulmonary embolism and stroke. Adequate anticoagulation therapy and vigilant monitoring are essential to mitigate these risks and ensure patient safety.
Complications such as catheter-related mechanical trauma, tissue damage, and allergic reactions to catheter materials or medications can occur, further complicating patient care and management. These complications may necessitate additional interventions, including catheter removal or replacement, to address adverse events and minimize patient harm.
Opportunities
- Emerging Markets Expansion
- Development of Novel Cannula Designs
-
Integration of Smart Technologies - One key opportunity lies in the development of smart angiostomy cannulas equipped with sensors and connectivity features that enable real-time monitoring of key physiological parameters and treatment metrics. These smart cannulas can provide clinicians with valuable insights into patient status, treatment efficacy, and potential complications, allowing for proactive interventions and personalized care delivery. By integrating sensors for continuous monitoring of parameters such as blood flow, pressure, temperature, and drug delivery rates, smart angiostomy cannulas enable early detection of adverse events and optimization of treatment strategies, ultimately improving patient safety and clinical outcomes.
The integration of connectivity technologies such as Bluetooth, Wi-Fi, and cellular networks enables seamless data transmission from smart angiostomy cannulas to electronic health records (EHRs) and remote monitoring platforms. This connectivity facilitates remote patient monitoring, telemedicine consultations, and data-driven decision-making, enhancing care coordination, and enabling timely interventions regardless of geographical barriers. Additionally, smart angiostomy cannulas can support automated data analysis algorithms and machine learning models, enabling predictive analytics and personalized treatment recommendations based on individual patient data and clinical outcomes.
Another opportunity lies in the development of smart drug delivery systems integrated into angiostomy cannulas, enabling precise and personalized medication administration based on real-time patient data and treatment algorithms. These systems can deliver medications in response to specific physiological cues or pre-programmed dosing schedules, optimizing drug efficacy, minimizing side effects, and improving patient adherence to treatment regimens.
Competitive Landscape Analysis
Key players in Global Angiostomy Cannula Market include:
- Smith+Nephew
- Maquet Holding B.V. & Co. KG
- LivaNova PLC
- Edwards Lifesciences Corporation
- Medtronic
- Merck & Co Inc
- Terumo Corporation
- Medline Industries
- LP
- Cardinal Health
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Angiostomy Cannula Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Aging Population
-
Technological Advancements
-
Increasing Chronic Diseases
-
- Restraints
-
Regulatory Compliance Burden
-
Limited Reimbursement Policies
-
Potential Complications
-
- Opportunities
-
Emerging Markets Expansion
-
Development of Novel Cannula Designs
-
Integration of Smart Technologies
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Angiostomy Cannula Market, By Type, 2021 - 2031 (USD Million)
- Cardiac Cannula
- Vascular Cannula
- Arthroscopy Cannula
- Dermatology Cannula
- Nasal Cannula
- Floating Spinal Cannula
- Hysterosalpingography Cannula
- Global Angiostomy Cannula Market, By Application, 2021 - 2031 (USD Million)
- Cardiovascular Surgery
- Oxygen Therapy
- Diabetes Treatment
- Neurology
- General Surgery
- Cosmetic/Plastic Surgery
- Global Angiostomy Cannula Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Angiostomy Cannula Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Smith+Nephew
- Maquet Holding B.V. & Co. KG
- LivaNova PLC
- Edwards Lifesciences Corporation
- Medtronic
- Merck & Co Inc
- Terumo Corporation
- Medline Industries
- LP
- Cardinal Health
- Company Profiles
- Analyst Views
- Future Outlook of the Market